AGE RELATED MACULAR DEGENERATION (ARMD)
Clinical trials for AGE RELATED MACULAR DEGENERATION (ARMD) explained in plain language.
Never miss a new study
Get alerted when new AGE RELATED MACULAR DEGENERATION (ARMD) trials appear
Sign up with your email to follow new studies for AGE RELATED MACULAR DEGENERATION (ARMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a tiny zap save your sight? new device trial for dry AMD
Disease control Recruiting nowThis study tests a device that delivers tiny electrical pulses through the eyelid to the back of the eye. The goal is to see if it can safely slow vision loss or improve sight in people with intermediate to advanced dry age-related macular degeneration. One hundred participants w…
Matched conditions: AGE RELATED MACULAR DEGENERATION (ARMD)
Phase: NA • Sponsor: i-Lumen Scientific AUS PTY LTD • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill for macular degeneration enters first human tests
Disease control Recruiting nowThis early-stage study tests an oral drug called ABF-101 in healthy adults and people with age-related macular degeneration (AMD). The main goal is to check safety and how the body processes the drug. About 68 participants will take either ABF-101 or a placebo to see if it is wel…
Matched conditions: AGE RELATED MACULAR DEGENERATION (ARMD)
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC